All News

hemotune raises CHF 5.1 million Series A funding

12-08-2020 – hemotune announced today that its spin-off hemotune AG has successfully closed their 5.1 million Series A funding round. The fundraising aims to advance the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads.

Despite the corona crisis, hemotune managed to build a very strong consortium led by OCCIDENT with participation of the Korean medical device company Green Cross Medical Science Corp. (GCMS), and Zürcher Kantonalbank.

Press Release (PDF)

Similar News

22-09-2020

Voliro closes CHF 2.0 million seed round

Voliro AG, a spin-off from ETH Zurich founded in 2019 and currently accelerated at Wyss Zurich, today announced the closing of a CHF 2.0 million seed round to develop advanced flying inspection...

The winners of the Startup Days 2020 including Hemotune and Sevensense

07-10-2020

hemotune and Sevensense among the winners of the Startup Days 2020

More than 250 startups were present at the Startup DAYS. About 100 of them competed in the Startup Battle. hemotune and Sevensense were among the ten startups that made it to finals and pitched to...

20-11-2020

hemotune wins Swiss Technology Award 2020

The Wyss Zurich project hemotune and its ETH spin-off win the Swiss Technology Award in the category "Startups". The prize is a great recognition for the startup and highlights its innovative...